Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Renal Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00323739
What this trial is testing

Bevacizumab (Avastin) and RAD001(Everolimus)in the Treatment of Advanced Clear Cell Renal Carcinoma

Who this might be right for
Kidney Cancer
SCRI Development Innovations, LLC 80
Testing effectiveness (Phase 2)Study completedNCT00688753
What this trial is testing

RAPTOR: RAD001 as Monotherapy in the Treatment of Advanced Papillary Renal Cell Tumors Program in Europe

Who this might be right for
CarcinomaRenal CellNon Clear Cell Renal Carcinoma+2 more
Novartis Pharmaceuticals 92
Testing effectiveness (Phase 2)UnknownNCT05865730
What this trial is testing

Oncobax®-AK in Patients With Advanced Solid Tumors

Who this might be right for
Carcinoma, Renal CellCarcinoma, Non-Small-Cell Lung
EverImmune 122
Testing effectiveness (Phase 2)Study completedNCT03163667
What this trial is testing

CB-839 With Everolimus vs. Placebo With Everolimus in Participants With Renal Cell Carcinoma (RCC)

Who this might be right for
Clear Cell Renal Cell Carcinoma
Calithera Biosciences, Inc 69
Early research (Phase 1)Ended earlyNCT06580938
What this trial is testing

Learn About PF-07921585 Alone or With Other Anti-cancer Medicines in People With Cancer

Who this might be right for
Non Small Cell Lung CancerBladder CancerRenal Cell Carcinoma+3 more
Pfizer 4
Early research (Phase 1)Study completedNCT02009449
What this trial is testing

Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors

Who this might be right for
MelanomaProstate CancerOvarian Cancer+6 more
Eli Lilly and Company 353
Early research (Phase 1)Study completedNCT01844947
What this trial is testing

Phase I Study With Sorafenib in Addition to Vinflunine in Metastatic Transitional Cell Carcinoma of the Urothelial Tract

Who this might be right for
Urothelial CarcinomaBladder CancerRenal Pelvis Cancer+2 more
Dr Anders Ullén 22
Early research (Phase 1)Ended earlyNCT00005655
What this trial is testing

Combination Therapy of Interleukin-12 and Interleukin-2 to Treat Advanced Cancer

Who this might be right for
Kidney NeoplasmLung NeoplasmSarcoma+1 more
National Cancer Institute (NCI) 39
Testing effectiveness (Phase 2)UnknownNCT00873236
What this trial is testing

MRI Scans of Blood Vessel Changes Caused by Bevacizumab Alone or Given Together With Interferon Alpha-2a in Treating Patients With Stage III or Stage IV Kidney Cancer

Who this might be right for
Kidney Cancer
Mount Vernon Cancer Centre at Mount Vernon Hospital 30
Testing effectiveness (Phase 2)UnknownNCT05013099
What this trial is testing

Study of Zirconium Zr 89 Crefmirlimab Berdoxam PET/CT in Subjects With Advanced or Metastatic Malignancies

Who this might be right for
MelanomaMerkel Cell Carcinoma, UnspecifiedRenal Cell Carcinoma+1 more
ImaginAb, Inc. 70
Testing effectiveness (Phase 2)Study completedNCT03693612
What this trial is testing

GSK3359609 Plus Tremelimumab for the Treatment of Advanced Solid Tumors

Who this might be right for
Neoplasms
GlaxoSmithKline 26
Not applicableWithdrawnNCT04941365
What this trial is testing

Quantifying Systemic Immunosuppression to Personalize Cancer Therapy

Who this might be right for
Metastatic MelanomaMetastatic Breast CancerAdvanced Renal Cell Carcinoma+3 more
Institut du Cancer de Montpellier - Val d'Aurelle
Testing effectiveness (Phase 2)Ended earlyNCT04088500
What this trial is testing

Combination Nivolumab and Ipilimumab Retreatment in Patients With Advanced Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Bristol-Myers Squibb 5
Not applicableUnknownNCT05135832
What this trial is testing

Patient Reported Outcomes by Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell CarcinomaKidney CancerKidney Neoplasm+3 more
Herlev and Gentofte Hospital 174
Testing effectiveness (Phase 2)UnknownNCT01444807
What this trial is testing

Evaluate the Efficacy of Sorafenib in Renal Cell Carcinoma Patients After a Radical Resection of the Metastases

Who this might be right for
Metastatic Renal Cell Carcinoma
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 132
Early research (Phase 1)UnknownNCT05420519
What this trial is testing

Clinical Study of CD70-targeted CAR-T Therapy for Advanced/Advanced Renal Cancer

Who this might be right for
Metastatic TumorRenal Cell CarcinomaAdvanced Cancer
Chongqing Precision Biotech Co., Ltd 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06730932
What this trial is testing

A Prospective，Single Arm, Multicenter Clinical Study of BTLA Monoclonal Antibody JS004 (B/T Lymphocyte Attenuator Factor Monoclonal Antibody) in Combination With Toripalimab in Patients With Unresectable or Advanced Renal Cell Carcinoma Who Had Failed Previous Immunotherapy

Who this might be right for
Unresectable or Advanced Clear Cell Renal Cell Carcinoma That Has Progressed After Previous Immunotherapy
RenJi Hospital 31
Early research (Phase 1)Study completedNCT01182168
What this trial is testing

Gemcitabine and Split-Dose Cisplatin Plus Everolimus (RAD001) in Patients With Advanced Solid Tumor Malignancies

Who this might be right for
Bladder CancerRenal Pelvis CancerUreter Cancer
Memorial Sloan Kettering Cancer Center 12
Testing effectiveness (Phase 2)Study completedNCT00002914
What this trial is testing

Piritrexim in Treating Patients With Advanced Cancer of the Urinary Tract

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
Eastern Cooperative Oncology Group 40
Early research (Phase 1)Ended earlyNCT02947152
What this trial is testing

HKT288 in Solid Tumors, Including Epithelial Ovarian Cancer and Renal Cell Carcinoma

Who this might be right for
Epithelial Ovarian CancerRenal Cell Carcinoma
Novartis Pharmaceuticals 9
Next Page